tsn

Separating MDMA: First Study Investigates Differences Between MDMA's Two Molecular Counterparts in Humans

 102
0 comment
Content Curator at Trial Site News | Journalist specializing in research on psychedelics and the therapeutic potentials of psychoactives
Aug. 28, 2024, 4:00 p.m.
Journalist Article

A new study published in Nature offers the first exploration of how MDMA's two molecular forms—S-MDMA and R-MDMA—differ in their effects on humans. The findings reveal that while S-MDMA may enhance therapeutic empathy, it also could also carry a heightened risk of post-treatment depression and possibly cardiac issues.

Enantiomers are mirror-image versions of molecules that can produce distinct biological effects because of their different-sided shapes. In mental health treatments, one enantiomer might more strongly activate specific proteins in the brain, leading to different biological effects. This could influence both the therapeutic outcomes and risks of a certain drug. 

Quality journalism costs money to produce.

Free access provides up to 10 articles

Subscription options start at $5 per month 
which is less than a Starbucks coffee!

Peter Gabriel, MD
"Publishing on TrialSite helped me secure a $20m research grant for my work."
Jona Savinda
"TrialSiteNews is my daily read for what is happening in the industry."
Lucas Van Der Hoven
"Objective, unbiased reporting on the latest news in medical research. I trust TrialSiteNews to give it to me straight."
TrialSiteNews
159 W Broadway, Suite 200
Salt Lake City, UT 84101
© 2025 - Trial Site News